A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-β oligomeric complexes

Journal of Neurochemistry

Volumn 98, Issue 1, 2006, Pages 57-67

  Maezawa, Izumi ^a   Hong, Hyun Seok ^a   Wu, Hui Chuan ^b   Battina, Srinivas K ^b   Rana, Sandeep ^b   Iwamoto, Takeo ^b   Radke, Gary A ^b   Pettersson, Erik ^b   Martin, George M ^c   Hua, Duy H ^b   Jin, Lee Way ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Amyloid; Intracellular; Oligomer; Small molecule; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; OLIGOMER; PYRONE DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; ATTENUATION; BRAIN CELL; CELL DEATH; CELL LINE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONTROLLED STUDY; NEUROBLASTOMA CELL; OLIGOMERIZATION; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; CARBAMATES; CELL COUNT; CELL DEATH; CELL LINE, TUMOR; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTRACELLULAR SPACE; MICROSCOPY, ATOMIC FORCE; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; PYRONES; SURFACE PLASMON RESONANCE; TIME FACTORS;

EID: 33745058712     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03862.x     Document Type: Article

References (46)

1. Almeida C. G. Tampellini D. Takahashi R. H. Greengard P. Lin M. T. Snyder E. M. Gouras G. K. ( 2005) β-Amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 20, 187 198.
2. Billings L. M. Oddo S. Green K. N. et al. ( 2005) Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675 688.
3. Blanchard B. J. Chen A. Rozeboom L. M. et al. ( 2004) Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc. Natl Acad. Sci. USA 101, 14326 14332.
4. Casas C. Sergeant N. Itier J. M. et al. ( 2004) Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165, 1289 1300.
5. Cataldo A. M. Petanceska S. Terio N. B. et al. ( 2004) Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down's syndrome. Neurobiol. Aging 25, 1263 1272.
6. Chromy B. A. Nowak R. J. Lambert M. P. et al. ( 2003) Self-assembly of Aβ(1-42) into globular neurotoxins. Biochemistry 42, 12 749 12 760.
7. Dahlgren K. N. Manelli A. M. Stine W. B. et al. ( 2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32 046 32 053.
8. Doerfler P. Shearman M. S. Perlmutter R. M. ( 2001) Presenilin-dependent γ-secretase activity modulates thymocyte development. Proc. Natl Acad. Sci. USA 98, 9312 9317.
9. Gouras G. K. Almeida C. G. Takahashi R. H. ( 2005) Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26, 1235 1244.
10. Greene L. A. ( 1978) Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78, 747 755.
11. Hua D. H. Chen Y. Sin H.-S. et al. ( 1997a) A one-pot condensation of pyrones and enals. Synthesis of 1H,7H-5a,6,8,9-tetrahydrol.-1-oxopyrano[4,3-b] [1]benzopyrans. J. Org. Chem. 62, 6888 6896.
12. Hua D. H. Chen Y. Robinson P. D. et al. ( 1997b) (5aS,7S)-7-Isopropenyl- 3-methyl-5a,6,8,9-tetrahydro-1H,7H-pyrano[4,3-b][1]-benzo-pyran-1-one. Acta Cryst. C53, 1995 1997.
13. Hua D. H. Huang X. Tamura M. et al. ( 2003) Synthesis and bioactivities of tricyclic pyrones. Tetrahedron 59, 4795 4803.
14. Hutter-Paier B. Huttunen H. J. Puglielli L. et al. ( 2004) The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44, 227 238.
15. Inestrosa N. C. Alvarez A. Perez C. A. et al. ( 1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16, 881 891.
16. Ishii K. Klunk W. E. Arawaka S. et al. ( 2002) Chrysamine G and its derivative reduce amyloid β-induced neurotoxicity in mice. Neurosci. Lett. 333, 5 8.
17. Jin L.-W. Hua D. H. Shie F. S. et al. ( 2002) Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death. J. Mol. Neurosci. 19, 57 61.
18. Jin L.-W. Maezawa I. Vincent I. et al. ( 2004) Intracellular accumulation of amyloidogenic fragments of amyloid-β precursor protein in neurons with Niemann-Pick-type C defects is associated with endosomal abnormalities. Am. J. Pathol. 164, 975 985.
19. Karlsson R. ( 2004) SPR for molecular interaction analysis: a review of emerging application areas. J. Mol. Recognit. 17, 151 161.
20. Kayed R. Sokolov Y. Edmonds B. et al. ( 2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. 279, 46 363 46 366.
21. Kienlen-Campard P. Miolet S. Tasiaux B. et al. ( 2002) Intracellular amyloid-β1-42, but not extracellular soluble amyloid-β peptides, induces neuronal apoptosis. J. Biol. Chem. 277, 15 666 15 670.
22. Lim G. P. Chu T. Yang F. et al. ( 2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370 8377.
23. Lipinski C. A. Lombardo F. Dominy B. W. Feeney P. J. ( 2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3 25.
24. Lorenzo A. Yankner B. A. ( 1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl Acad. Sci. USA 91, 12 243 12 247.
25. Lu D. C. Rabizadeh S. Chandra S. et al. ( 2000) A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor. Nat. Med. 6, 397 404.
26. Maezawa I. Jin L.-W. Woltjer R. L. et al. ( 2004) Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-mediated cytotoxicity through different mechanisms. J. Neurochem. 91, 1312 1321.
27. Myszka D. G. ( 2004) Analysis of small-molecule interactions using Biacore S51 technology. Anal. Biochem. 329, 316 323.
28. Omura S. Tomoda H. Kim Y. K. et al. ( 1993) Pyripyropenes, highly potent inhibitors of acyl-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus. J. Antibiot. 46, 1168 1169.
29. Omura S. Kuno F. Otoguro K. et al. ( 1995) Arisugacin, a novel and selective inhibitor of acetylcholinesterase from Penicillium sp. FO-4259. J. Antibiot. 48, 745 746.
30. Pike C. J. Burdick D. Walencewicz A. J. et al. ( 1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676 1687.
31. Podlisny M. B. Walsh D. M. Amarante P. et al. ( 1998) Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 37, 3602 3611.
32. Shie F. S. LeBoeuf R. C. Jin L. W. ( 2003) Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice. Neuroreport 14, 123 129.
33. Sopher B. L. Fukuchi K. Smith A. C. et al. ( 1994) Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the β-amyloid precursor protein. Brain Res. Mol. Brain Res. 26, 207 217.
34. Sopher B. L. Fukuchi K. Kavanagh T. J. et al. ( 1996) Neurodegenerative mechanisms in Alzheimer's disease. A role for oxidative damage in amyloid β protein precursor-mediated cell death. Mol. Chem. Neuropathol. 29, 153 168.
35. de Souza R. F. Sussuchi E. M. De Giovani W. F. ( 2003) Synthesis, electrochemical, spectral, and antioxidant properties of complexes of flavanoids with metal ions. Syn. React. Inorg. Metalorg. Chem. 33, 1125 1144.
36. Takahashi R. H. Almeida C. G. Kearney P. F. et al. ( 2004) Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 3592 3599.
37. Tan S. Sagara Y. Liu Y. et al. ( 1998) The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423 1432.
38. Thinakaran G. Teplow D. B. Siman R. et al. ( 1996) Metabolism of the 'Swedish' amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the 'β-secretase' site occurs in the golgi apparatus. J. Biol. Chem. 271, 9390 9397.
39. Tjernberg L. O. Naslund J. Lindqvist F. et al. ( 1996) Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271, 8545 8548.
40. Walsh D. M. Tseng B. P. Rydel R. E. et al. ( 2000) The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10 831 10 839.
41. Walsh D. M. Klyubin I. Fadeeva J. V. et al. ( 2002) Amyloid-β oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30, 552 557.
42. Walsh D. M. Townsend M. Podlisny M. B. et al. ( 2005) Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation. J. Neurosci. 25, 2455 2462.
43. Wirths O. Multhaup G. Bayer T. A. ( 2004) A modified β-amyloid hypothesis: intraneuronal accumulation of the β-amyloid peptide - the first step of a fatal cascade. J. Neurochem. 91, 513 520.
44. Woltjer R. L. Nghiem W. Maezawa I. et al. ( 2005) Role of glutathione in intracellular amyloid-α precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J. Neurochem. 93, 1047 1056.
45. Yang F. Lim G. P. Begum A. N. et al. ( 2005) Curcumin inhibits formation of Aβ oligomers and fibrils and binds plaques and reduces amyloid in vivo. J. Biol. Chem. 280, 5892 5901.
46. Zhang Y. McLaughlin R. Goodyer C. et al. ( 2002) Selective cytotoxicity of intracellular amyloid β peptide 1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156, 519 529.